Altered differentiation is central to HIV-specific CD4+ T cell dysfunction in progressive disease
Antigoni Morou(Université de Montréal), Daniel E. Kaufmann(International AIDS Vaccine Initiative), Premeela A. Rajakumar(Emory University), Nathalie Brassard(Université de Montréal), R. Paul Johnson(Emory University), Elsa Brunet‐Ratnasingham(Centre Hospitalier de l’Université de Montréal), Julia Niessl(International AIDS Vaccine Initiative), Daniel C. Douek(National Institutes of Health), Richard T. Wyatt(Scripps Research Institute), Jean‐Pierre Routy(McGill University Health Centre), Roxanne Charlebois(Centre Hospitalier de l’Université de Montréal), Sahaana Arumugam, Cécile Tremblay(Institut National de Santé Publique du Québec), Krystelle Nganou‐Makamdop, James M. Billingsley(Emory University), Amy E. Baxter(Translational Therapeutics (United States)), Samuel Darko, Lifei Yang(Ningbo No. 2 Hospital), François Lefebvre(Ontario Genomics), Andrés Finzi(Centre Hospitalier de l’Université de Montréal), Gabrielle Gendron‐Lepage(Centre Hospitalier de l’Université de Montréal), Eloi Mercier(Ontario Genomics), Mathieu Dubé(Centre Hospitalier de l’Université de Montréal)
Cited by 108
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection
|New England Journal of Medicine|2015|1.6k
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
|New England Journal of Medicine|2002|1.1k
Systemic Effects of Inflammation on Health during Chronic HIV Infection
|Immunity|2013|835